ARTICLE | Clinical News
Letairis ambrisentan: Phase III data
June 2, 2008 7:00 AM UTC
Previously reported data from the double-blind Phase III ARIES-1 and ARIES-2 trials in 394 patients were published in Circulation and showed that Letairis ambrisentan met the primary endpoint of place...